RxDoctor Payments Data

Alan Leifeste

Family Medicine · Kingsland, TXNPI 1700988714

Payments from drug & device makers

$2,745in general payments, 2019–2025

Across 126 payments — averaging $21.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Boehringer Ingelheim$251
  • Medtronic$232
  • Globus Medical$175
  • AstraZeneca$167
  • Inspire Medical Systems, Inc.$146
  • plus $534 from 12 others

What the payments were for

  • Food & beverage$2,73299%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,745 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide255$392,741
JardianceEmpagliflozin165$198,254
Repatha SureclickEvolocumab95$102,806
EliquisApixaban163$95,885
TrulicityDulaglutide34$54,409
MyrbetriqMirabegron83$49,552
XareltoRivaroxaban94$49,278
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$38,959
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog33$38,250
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$32,030
JanuviaSitagliptin Phosphate38$23,405
Lantus SolostarInsulin Glargine,hum.Rec.Anlog127$16,346
Rosuvastatin Calcium1,121$13,911
Combivent RespimatIpratropium/Albuterol Sulfate20$10,522
Duloxetine Hcl458$10,346

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$392,741255 claims
Boehringer IngelheimJardiance, Combivent Respimat$251$208,776185 claims
Astellas Pharma US IncMyrbetriq$19$49,55283 claims
AstraZenecaBrilinta, Symbicort$167$12,79939 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$7,465717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Kingsland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →